[Efficacy of medical therapy in preventing the post-surgical recurrence in Crohn's disease].
Crohns Disease (CD) is a chronic intestinal inflammatory disease of unknown origins that cannot be definitely resolved with surgical intervention. Therefore, pharmacologic therapies are of great importance both in preventing relapses and by determining remissions. In this paper the authors analyse the different drugs available for the treatment of Crohns disease, and focus on their efficacy and tollerability.
Ardizzone
S
S
Cattedra e Divisione di Gastroenterologia, Università degli Studi di Milano, Dipartimento di Scienze Cliniche "Luigi Sacco", Ospedale Luigi Sacco, Azienda Ospedaliera Polo Universitario, Milano.
Bollani
S
S
Manzionna
G
G
Colombo
E
E
Maconi
G
G
Imbesi
V
V
Bianchi Porro
G
G
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy / Q000517:prevention & control* / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D019804:Mesalamine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D012008:Recurrence; D016540:Smoking Cessation; D013256:Steroids / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D013256:Steroids; D014409:Tumor Necrosis Factor-alpha; D019804:Mesalamine; D015122:Mercaptopurine; D001379:Azathioprine; D008727:Methotrexate